Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top thi...
Even as most emerging economies in Asia Pacific are trying to grab a foothold in the global biopharma space, China has e...
Singapore: Anaphore changed its corporate name to RuiYi. As part of the company's shift in strategy to the R&D of n...
Singapore: Australia's peptide drug discovery company, Phylogica has received linkage grant from Australian Research Cou...
Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial c...
Singapore: AstraZeneca has completed its acquisition of Pearl Therapeutics, a privately held company based in Redwood Ci...
Singapore: Scientists at St. Jude Children's Research Hospital have reported details of how certain drugs can precisely ...
Singapore: Taiwan based TaiGen Biotechnology has recieved Taiwan Food and Drug Administration (TFDA) approval for new dr...
Singapore: Bionomics plans to raise up to approximately $16.4 million of funds to advance development programs across d...
Singapore: Takeda Pharmaceutical and Advinus Therapeutics jointly announced that they would be initiating a three-year d...
Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule...
Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltr...
Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined...
Singapore: Israel-based Compugen and global pharmaceutical company Bayer are to jointly pursue a preclinical research pr...
Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combina...
Singapore: Genentech, a member of the Roche Group, has recieved US FDA approval for Perjeta (pertuzumab) regimen for neo...
Singapore: The US Food and Drug Administration (FDA) has issued a complete response letter to Janssen Therapeutics for ...
Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, rec...
